Entero Healthcare Solutions Limited has informed the Exchange regarding Cessation of Mr Rajesh Shashikant Dalal as Non- Executive Independent Director of the company w.e.f. August 24, 2026.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Rajesh Shashikant Dalal (DIN: 03504969) has informed the board that he will not seek re-appointment as Non-Executive Independent Director for a second term. His current term ends on August 24, 2026, and he will cease to be a director from the close of business hours on that date. He will also step down as Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee, and as a member of the Audit Committee. The company has filed this disclosure under SEBI Listing Regulations with the required annexure.
This is a routine end-of-term non-renewal for a single independent director and is unlikely to materially affect the stock. Shareholders should note that the company will need to fill the vacated independent director seat and committee positions in due course.